Human health implications of emerging diseases and the current situation in India's vaccine industry

Emerging diseases are infectious diseases that pose significant threat to human health,causing millions of deaths and disabilities in the upcoming days.Periodic epidemics of new infections and old reinfections increase the global burden of disease prevalence.They can be caused by new pathogens or evolving ones,which change human behavior and environmental factors.Researchers have studied the dynamic connections between microbes,hosts,and the environment,but new infectious diseases like coronavirus disease 2019(COVID-19),re-emerging diseases,and deliberately disseminated diseases persist despite earlier hopes of elimination.With heavy privatesector investments,Indian pharmacology now provides core Expanded Programme on Immunization vaccines to United Nations International Children's Emergency Fund,producing previously unattainable vaccines for diseases like meningitis,hepatitis B,pneumococcal conjugate,rotavirus,influenza A(H1N1),and COVID-19.India's vaccine sector has emerged,among the oriented leaders of the Bharat Biotech,Serum Institute of India,Panacea Biotech and Biological E.Specifically,the technology transferred from Western countries has benefited the sector,which produces 1.3 billion doses annually.The Serum Institute is the world's largest manufacturer of vaccines,providing measles and diphtheria-tetanus-pertussis vaccines to United Nations.The Serum Institute has developed several vaccines,including Nasovac,MenAfriVac,Pentavac,and an inactivated polio vaccine.India's success in vaccinations can be attributed to attractive investment conditions,government assistance,international alliances,and rising domestic technical talent.Despite its booming economy and technical advances,India's disproportionate share of the world's child mortality rate remains unchanged.However,the growing production and distribution of vaccinations in developing nations has initiated a new era,leading to a worldwide decline in childhood death and disease.

Modern technologies and solutions to enhance surveillance and response systems for emerging zoonotic diseases

Background:Zoonotic diseases originating in animals pose a significant threat to global public health.Recent outbreaks,such as coronavirus disease 2019(COVID-19),have caused widespread illness,death,and socioeconomic disruptions worldwide.To cope with these diseases effectively,it is crucial to strengthen surveillance capabilities and establish rapid response systems.Aim:The aim of this review is to examine the modern technologies and solutions that have the potential to enhance zoonotic disease surveillance and outbreak responses and provide valuable insights into how cuttingedge innovations could be leveraged to prevent,detect,and control emerging zoonotic disease outbreaks.Herein,we discuss advanced tools including big data analytics,artificial intelligence,the Internet of Things,geographic information systems,remote sensing,molecular diagnostics,point-of-care testing,telemedicine,digital contact tracing,and early warning systems.Results:These technologies enable real-time monitoring,the prediction of outbreak risks,early anomaly detection,rapid diagnosis,and targeted interventions during outbreaks.When integrated through collaborative partnerships,these strategies can significantly improve the speed and effectiveness of zoonotic disease control.However,several challenges persist,particularly in resource-limited settings,such as infrastructure limitations,costs,data integration and training requirements,and ethical implementation.Conclusion:With strategic planning and coordinated efforts,modern technologies and solutions offer immense potential to bolster surveillance and outbreak responses,and serve as a critical resource against emerging zoonotic disease threats worldwide.

美国《Emerging Infectious Diseases》2018年第10期有关人兽共患病论文摘译

P1795中国甲型流感病毒(H7N9)的分子进化、多样性和适应性//Jing Lu,Jayna Raghwani,Rhys Pryce,等2016-2017年,抗原性差异或高致病性甲型流感(H7N9)病毒的出现和流行的大幅上升,引起了人们对这些病毒可能引起人兽共患病的关注。

Public perceptions about the emerging human monkey pox disease and vaccination in twin cities of Pakistan: a cross-sectional study

Background:The monkey pox virus is caused by monkey pox(MPX),which is similar to both smallpox and cowpox.Near tropical rain forests,it usually occurs in isolated communities in Central and West Africa.The monkey pox virus,a member of the family Poxviridae and belongs to the genus Orthopoxvirus.Close contact with infected animals,sick people,or contaminated inanimate things can cause the virus to spread to humans.The illness typically takes 7 to 14 days to incubate and is characterized by fever,headache,lethargy,myalgia,generalized body pains,lymph node swelling,and skin lesions.Given the variety of illnesses that can result in skin rashes,it could be challenging to differentiate monkey pox solely based on clinical presentation,particularly for patients with an uncommon look.Objective:The main objective of the study is to evaluate public perceptions regarding the emerging human monkey pox disease and vaccination.Methods:The study was conducted using a cross-sectional study design.The sample size was 472 participants;however,10 questionnaires were excluded because of invalid data.The 462 questionnaires were included by expert validation from the general public of Rawalpindi and Islamabad,Pakistan.The data were analyzed using Chi-squared tests.Results:This questionnaire-based cross-sectional study was conducted from 15 Sep to 15 Oct 2022.The participants’perceptions,knowledge,and attitudes were collected via a 24-item-based questionnaire survey.The survey was based on 462 participants,196(42.4%)were females,and 266(57.6%)were males.The results reveal that out of 462 participants,clinical symptoms of monkey pox disease 82.7%(382),complications of monkey pox disease 81.2%(375),lymphadenopathy(swollen lymph nodes)is one clinical feature that could be used to differentiate between monkey pox and smallpox 81.2%(375)and monkey pox is common in Western and Central Africa 24.2%(112).Furthermore,the majority of participants(P≤0.05)agreed that health officials should start a vaccination campaign to combat monkey pox.Regarding preventive measures and vaccination campaigns,health officials should take public preventive measures 79.7%(368)and health officials start a vaccination campaign against monkey pox disease 56.3%(260).Conclusion:There was a significant difference seen in the public perception regarding monkey pox preventive measures and vaccination.The International health authorities must take priority-based preventative measures to prevent the spread of monkey pox disease around the world.

美国《Emerging Infectious Diseases》2023年第6期有关人兽共患病论文摘译

P1091神经莱姆病后持续症状与血液中IFN-α水平升高的相关性//Sergio A.Hernández,Katarina Ogrinc,Mi?a Korva,等神经莱姆病(LNB)患者尽管接受抗生素药物治疗,仍可能会经历持续的症状。本文对79例LNB患者的血清和脑脊液(CSF)中20种免疫介质进行为期1年的检测,来验证这些症状是否由适应性免疫反应异常引起。在研究初期,大多数介质高度集中在CSF感染的部位。

美国《Emerging Infectious Diseases》2023年第8期有关人兽共患病论文摘译

P1506日本溃疡棒状杆菌感染的临床特点//Akihiko Yamamoto,Toru Hifumi,Manabu Ato,等,溃疡棒状杆菌是一种与白喉杆菌密切相关的细菌,一些溃疡杆菌菌株产生的毒素与白喉杆菌毒素相似。溃疡菌在环境中到处可见,被认为是对牲畜和野生动物最有害的病原体之一。

Ecological Barrier Deterioration Driven by Human Activities Poses Fatal Threats to Public Health due to Emerging Infectious Diseases

The coronavirus disease 2019(COVID-19)and concerns about several other pandemics in the 21st century have attracted extensive global attention.These emerging infectious diseases threaten global public health and raise urgent studies on unraveling the underlying mechanisms of their transmission from animals to humans.Although numerous works have intensively discussed the cross-species and endemic barriers to the occurrence and spread of emerging infectious diseases,both types of barriers play synergistic roles in wildlife habitats.Thus far,there is still a lack of a complete understanding of viral diffusion,migration,and transmission in ecosystems from a macro perspective.In this review,we conceptualize the ecological barrier that represents the combined effects of cross-species and endemic barriers for either the natural or intermediate hosts of viruses.We comprehensively discuss the key influential factors affecting the ecological barrier against viral transmission from virus hosts in their natural habitats into human society,including transmission routes,contact probability,contact frequency,and viral characteristics.Considering the significant impacts of human activities and global industrialization on the strength of the ecological barrier,ecological barrier deterioration driven by human activities is critically analyzed for potential mechanisms.Global climate change can trigger and expand the range of emerging infectious diseases,and human disturbances promote higher contact frequency and greater transmission possibility.In addition,globalization drives more transmission routes and produces new high-risk regions in city areas.This review aims to provide a new concept for and comprehensive evidence of the ecological barrier blocking the transmission and spread of emerging infectious diseases.It also offers new insights into potential strategies to protect the ecological barrier and reduce the wide-ranging risks of emerging infectious diseases to public health.

Advances in Acute Emerging Infectious Disease Symptom Monitoring

In recent years,the risk of acute emerging infectious diseases has increased significantly due to changes in environmental conditions and social factors,posing a serious threat to public health security and human health.The general susceptibility of the population and the unpredictability and increasing infectiousness of emerging infectious diseases reflect the inadequacy of the existing infectious disease surveillance system for timely detection and screening of emerging infectious diseases,often leading to a certain scale of epidemic outbreaks that seriously harm humans before being detected passively.This is a literature review on symptom surveillance of acute emerging infectious diseases at home and abroad,emphasizing on the subject matter and development of symptom surveillance of emerging infectious diseases,so as to provide a scientific basis for the establishment and improvement of symptom surveillance of acute emerging infectious diseases.

The emerging epigenetics of PARK7 and its implication in neurodegenerative disease

PARK7/DJ-1 is a multifunctional protein that acts as a regulator in stress responsive cascades.Since its original discovery as a novel oncogene,DJ-1 was further implicated in the correspondingly dubbed PARK7 autosomal recessive early onset Parkinson’s Disease variant,expanding the spectrum of its pathophysiologyto neurodegenerative disease.

Surveillance and response strategies for zoonotic diseases:a comprehensive review

Out of all emerging infectious diseases, approximately 75% are of zoonotic origin, with their source often traced back to animals. The emergence of zoonoses is driven by a complex interplay between anthropogenic, genetic, ecological, socioeconomic, and climatic factors. This intricate web of influences poses significant challenges for the prediction and prevention of zoonotic outbreaks. Effective coordination and collaboration among the animal, human, and environmental health sectors are essential for proactively addressing major zoonotic diseases. Despite advancements in surveillance and diagnostic practices, the emergence of zoonoses continues to be a pressing global concern. Therefore, prioritizing zoonotic disease surveillance is of paramount importance as part of a comprehensive disease prevention and containment strategy. Furthermore, evaluating existing surveillance systems provides insights into the challenges faced, which can be mitigated through implementation of One Health principles involving relevant stakeholders. To initiate multisectoral partnerships, it is crucial to identify the priorities and core themes of surveillance systems with equitable inputs from various sectors. Strengthening surveillance, promoting data sharing, enhancing laboratory testing capabilities, and fostering joint outbreak responses in both the human and animal health sectors will establish the necessary infrastructure to effectively prevent, predict, detect, and respond to emerging health threats, thereby reinforcing global health security. This review assesses existing surveillance approaches by offering an overview of global agencies engaged in monitoring zoonoses and outlines the essential components required at the human–animal–environment interface for designing comprehensive surveillance networks. Additionally, it discusses the key steps necessary for executing effective zoonotic disease surveillance through a One Health approach, while highlighting the key challenges encountered in establishing such a robust surveillance system.

Building a pathway to One Health surveillance and response in Asian countries

To detect and respond to emerging diseases more effectively,an integrated surveillance strategy needs to be applied to both human and animal health.Current programs in Asian countries operate separately for the two sectors and are principally concerned with detection of events that represent a short-term disease threat.It is not realistic to either invest only in efforts to detect emerging diseases,or to rely solely on event-based surveillance.A comprehensive strategy is needed,concurrently investigating and managing endemic zoonoses,studying evolving diseases which change their character and importance due to influences such as demographic and climatic change,and enhancing understanding of factors which are likely to influence the emergence of new pathogens.This requires utilisation of additional investigation tools that have become available in recent years but are not yet being used to full effect.As yet there is no fully formed blueprint that can be applied in Asian countries.Hence a three-step pathway is proposed to move towards the goal of comprehensive One Health disease surveillance and response.